Status:
COMPLETED
Adherence to Hydroxyurea in Children With Sickle Cell Anemia
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Sickle Cell Anemia
Eligibility:
All Genders
2-17 years
Phase:
NA
Brief Summary
Medication non-adherence is a true public health problem. Despite advancements in the molecular understanding of disease and improvements in therapy, patient health outcomes will not improve unless pa...
Eligibility Criteria
Inclusion
- Sickle cell anemia
- on Hydroxyurea for at least six months
- age 2-17.9 years
Exclusion
- none
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00672789
Start Date
April 1 2008
End Date
November 1 2012
Last Update
May 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710